On Friday's broadcast of CNN's "Situation Room," FDA Vaccines and Related Biological Products Advisory Committee member Dr. Paul Offit stated that "in many ways, the FDA and CDC were marginalized" by the Biden administration's handling of coronavirus vaccine boosters, but the administration did eventually "let this process play out the way it should have played out at the beginning." Offit also argued that labeling cases with mild or no symptoms as breakthrough infections "created an expectation for this vaccine that, frankly, was unfair."